Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Paraneoplastic antigen Ma6F (PNMA6F)
- Target
- PNMA6F
- Molecular classification
- Other, Paraneoplastic antigen family (PNMA family)
01
Overview
Paraneoplastic antigen Ma6F is a member of the PNMA (paraneoplastic Ma antigen) gene family, which encodes proteins often recognized by autoantibodies in paraneoplastic neurological syndromes. PNMA6F is a protein-coding gene located on the X chromosome and characterized mainly by sequence or structural similarity to other paraneoplastic antigens[1][10][12]. Its physiological role remains undetermined, and there is no published evidence of its activity as a receptor, enzyme, or therapeutic target. No functional, pharmacological, or pathophysiological relevance has been established, and no drug or clinical biomarker relationships have been reported to date[3][6].
- Other names
- PNMA family member 6FPNMA6BLparaneoplastic Ma antigen family member 6Fparaneoplastic antigen-like protein 6B
02
Mechanism of action
None established (no targeting drugs or mechanism described)
03
Biological functions
Unknown (no direct biological function assigned; generally paraneoplastic antigens are implicated in autoimmune responses, but no specific function confirmed for PNMA6F)[3][10][12]
04
Disease associations
Other (paraneoplastic antigen family members are typically associated with paraneoplastic neurological syndromes, but there is no direct evidence for PNMA6F involvement in any human disease)[3][6]
Beyond the preview
Go deeper on Paraneoplastic antigen Ma6F (PNMA6F).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Paraneoplastic antigen Ma6F (PNMA6F).